aod9604 clinical trials obesity - Research Peptide AOD-9604 vs MOTS-c vs Tesamorelin

AOD9604 is studied for stimulating fat breakdown specifically, without the bone growth, muscle growth, or insulin resistance effects typically associated with full-length growth hormone administration

Catecholamines are the primary activators of fasting-induced lipolysis

Other benefits of this treatment include: Protect Bone Health As we grow older, we are all at higher risk of bone disease such as osteopenia, which is a condition that makes your bones more fragile as you age

Clinical check-in

The liberation of FA from TAG by adipocyte lipolysis is also important to supply substrate for hepatic synthesis of very-low-density lipoproteins (VLDLs)